{"title":"Water resource rejuvenation via AOP based degradation of pharmaceuticals extensively used during COVID-19","authors":"","doi":"10.1016/j.jwpe.2024.106137","DOIUrl":null,"url":null,"abstract":"<div><p>During COVID-19 (<strong>Co</strong>rona <strong>Vi</strong>rus <strong>D</strong>isease - 20<strong>19</strong>), pharmaceuticals such as hydroxychloroquine, remdesivir, azithromycin, dexamethasone, heparin, molnupiravir etc., have been rampantly used in the treatment drive. The pharmacokinetics data of these pharmaceuticals revealed that they are not entirely absorbed by the body and can be released in primary form into wastewater. These compounds have a very high tendency to persist, bio-accumulate, and transmit into living beings in nondegradable toxic forms. Consequently, the concentrations of these pharmaceuticals are rising swiftly in wastewater. Due to pandemic, the detected concentrations of these pharmaceuticals in aqueous medium are beyond the acceptable limits. Hence, they are emerging as the “newest concern” for water contamination. Accordingly, it demands urgent attention worldwide to develop newer and better processes for fast and efficient degradation of growing pharmaceutical contaminants (PC). Advanced oxidation processes (AOP) appear to be the supremely effective wastewater treatment technology with almost 100 % removal efficiency and greater mineralization of micropollutant compared to that with other processes. Therefore, this review attempts to elucidate the most significant information on the recent progresses associated with AOP-based degradation technologies applicable precisely for the elimination and mineralization of pharmaceuticals used during COVID-19.</p></div>","PeriodicalId":17528,"journal":{"name":"Journal of water process engineering","volume":null,"pages":null},"PeriodicalIF":6.3000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of water process engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214714424013692","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, CHEMICAL","Score":null,"Total":0}
引用次数: 0
Abstract
During COVID-19 (Corona Virus Disease - 2019), pharmaceuticals such as hydroxychloroquine, remdesivir, azithromycin, dexamethasone, heparin, molnupiravir etc., have been rampantly used in the treatment drive. The pharmacokinetics data of these pharmaceuticals revealed that they are not entirely absorbed by the body and can be released in primary form into wastewater. These compounds have a very high tendency to persist, bio-accumulate, and transmit into living beings in nondegradable toxic forms. Consequently, the concentrations of these pharmaceuticals are rising swiftly in wastewater. Due to pandemic, the detected concentrations of these pharmaceuticals in aqueous medium are beyond the acceptable limits. Hence, they are emerging as the “newest concern” for water contamination. Accordingly, it demands urgent attention worldwide to develop newer and better processes for fast and efficient degradation of growing pharmaceutical contaminants (PC). Advanced oxidation processes (AOP) appear to be the supremely effective wastewater treatment technology with almost 100 % removal efficiency and greater mineralization of micropollutant compared to that with other processes. Therefore, this review attempts to elucidate the most significant information on the recent progresses associated with AOP-based degradation technologies applicable precisely for the elimination and mineralization of pharmaceuticals used during COVID-19.
期刊介绍：
The Journal of Water Process Engineering aims to publish refereed, high-quality research papers with significant novelty and impact in all areas of the engineering of water and wastewater processing . Papers on advanced and novel treatment processes and technologies are particularly welcome. The Journal considers papers in areas such as nanotechnology and biotechnology applications in water, novel oxidation and separation processes, membrane processes (except those for desalination) , catalytic processes for the removal of water contaminants, sustainable processes, water reuse and recycling, water use and wastewater minimization, integrated/hybrid technology, process modeling of water treatment and novel treatment processes. Submissions on the subject of adsorbents, including standard measurements of adsorption kinetics and equilibrium will only be considered if there is a genuine case for novelty and contribution, for example highly novel, sustainable adsorbents and their use: papers on activated carbon-type materials derived from natural matter, or surfactant-modified clays and related minerals, would not fulfil this criterion. The Journal particularly welcomes contributions involving environmentally, economically and socially sustainable technology for water treatment, including those which are energy-efficient, with minimal or no chemical consumption, and capable of water recycling and reuse that minimizes the direct disposal of wastewater to the aquatic environment. Papers that describe novel ideas for solving issues related to water quality and availability are also welcome, as are those that show the transfer of techniques from other disciplines. The Journal will consider papers dealing with processes for various water matrices including drinking water (except desalination), domestic, urban and industrial wastewaters, in addition to their residues. It is expected that the journal will be of particular relevance to chemical and process engineers working in the field. The Journal welcomes Full Text papers, Short Communications, State-of-the-Art Reviews and Letters to Editors and Case Studies
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
